Old Europe Cheese's ready-to-eat Brie and Camembert were tied to a six-state Listeria outbreak and made under insanitary conditions.
What happened
FDA inspected the ready-to-eat cheese plant in Benton Harbor, Michigan, from September 13 to October 6, 2022, with Michigan agriculture officials after a multistate Listeria monocytogenes outbreak. CDC reported six illnesses in six states and five hospitalizations, and FDA said an environmental swab from a floor hole matched the outbreak strain. The company recalled Brie, Camembert, and Baked Brie and suspended production; FDA cited insanitary conditions and failures in the food-safety rules known as CGMP and preventive controls.
What FDA found
FDA said the hazard analysis wrongly concluded that Listeria contamination after pasteurization did not need a preventive control, even though the RTE cheese was exposed to the environment after pasteurization.
21 CFR 117.130(a)(1); 21 CFR 117.135(c)(3)FDA said the hazard analysis did not require a process control for pathogen growth in cooler storage, and records showed temperatures of 51.2°F to 53.1°F without documented corrective action.
21 CFR 117.130(a)(1); 21 CFR 117.135(c)(1); 21 CFR 117.160FDA said ingredients added after pasteurization, such as spices, had no kill step and the company lacked a required supply-chain program and annual onsite audits for Salmonella risk.
21 CFR 117.405(a)(1); 21 CFR 117.430(b)FDA found sanitation procedures were not followed: employees handled RTE brie after touching unclean surfaces without washing, a clean-in-place vat was not fully filled, molds had food residue, pre-operation checks were missed, and environmental swabs were not collected as scheduled.
21 CFR 117.135(a)FDA observed a hose spray hit the floor and then a cheese molding machine, which was used for brie without further cleaning.
21 CFR 117.35(a)FDA found condensation and dark stains on ceilings and pipes above exposed RTE cheese and food-contact molds, creating a drip contamination risk.
21 CFR 117.20(b)(4)
What FDA wants
FDA tells the company to complete and document its corrective actions--root cause investigation, facility repairs, revised food safety plan, and sanitation/environmental monitoring procedures--and provide additional information. The provided letter does not state a response deadline; FDA says it will evaluate adequacy once actions are complete and verify them at its next inspection.
Who should pay attention
- retailers and brands selling Brie or Camembert made by contract manufacturers
- RTE food plants with post-pasteurization exposure
- quality teams responsible for Listeria environmental monitoring and sanitation
This is a summary. Read the original letter on fda.gov.